Immediate Impact
1 from Science/Nature 66 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
2025 Standout
Works of Sorcha Cassidy being referenced
Bispecific antibodies in oncology
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Sorcha Cassidy | 191 | 66 | 16 | 96 | 77 | 11 | 366 | |
| M. Perricaudet | 154 | 65 | 5 | 137 | 99 | 9 | 372 | |
| W. Hylton | 145 | 41 | 18 | 74 | 41 | 16 | 337 | |
| Margot Revel | 249 | 29 | 13 | 116 | 76 | 14 | 394 | |
| Oppenheim Jj | 152 | 42 | 15 | 49 | 68 | 18 | 326 | |
| Weigang Shu | 137 | 55 | 5 | 141 | 62 | 10 | 349 | |
| Mary Bennett | 96 | 81 | 5 | 120 | 75 | 18 | 339 | |
| Zhao Yang Lu | 183 | 40 | 6 | 75 | 156 | 8 | 344 | |
| Laia Llinàs | 142 | 26 | 9 | 106 | 43 | 8 | 362 | |
| Subramanian Muthukkumar | 178 | 34 | 10 | 136 | 61 | 9 | 354 | |
| A. S. Coulson | 170 | 33 | 17 | 93 | 48 | 8 | 372 |
All Works
Login with ORCID to disown or claim papers
Loading papers...